16 August 2022
Australia is reliant on imports for the majority of its medicines - in this age of global epidemics regulatory vigilance has never been more important.
Tag: pharmaceutical industry
12 August 2022
Poverty drives the market in inferior medicines just as it drives other examples of inequality. A socially integrated approach is needed to fight the problem.
11 August 2022
India’s booming biopharma sector presents a new challenge for regulators.
26 July 2022
China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics. But its global ambitions might turn the industry upside down.
25 July 2022
The rampant trade in fake sexual stimulants is a reminder of how easy it is for sub-standard medicines to take hold and the need for greater public awareness.
22 July 2022
IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?
11 May 2022
The majority of unwanted or expired medicines are disposed of via household wastes, and only a minority are returned to pharmacies.
16 November 2021
MOH says sofosbuvir will be given to medical tourists at private hospitals after procuring the drug under a voluntary licence; WTO rules only allow compulsory licensing for public non-commercial use.
18 October 2021
By ending its ambivalence towards the protection of IP rights, the government can bridge the gap towards achieving its aspirations to be a globally competitive, high-income knowledge-economy.
13 October 2021
The most significant update with the Malaysian Guidelines on Good Pharmacovigilance Practices For Product Registration Holders, First Edition, August 2021 is the inclusion of a new Part 6 on the Pharmacovigilance System Master File.